ESAB director receives new option and DSU awards

ESAB Corp director Robert S. Lutz received new equity-based compensation awards.

Rhea-AI Filing Summary

ESAB Corp director Robert S. Lutz received new equity-based compensation awards. He was granted 2,647 stock options with an exercise price of $100.94 per share that vested and became exercisable on the grant date. He also received 813 deferred stock units, each representing one share of common stock.

The 813 deferred stock units vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after his separation from the company. These awards are classified as grants rather than open-market purchases or sales and represent routine director compensation.

Insider Trade Summary

Grant/Award: 3,460 shares

Grant/Award 2 txns

Insider LUTZ ROBERT S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	2,647	$0.00	$0.00
Grant/Award	Deferred Stock Units	813	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 2,647 contracts (Direct); Deferred Stock Units — 813 contracts (Direct)

Footnotes (3)

1. F1. These stock options vested and became exercisable on the grant date.
2. F2. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
3. F3. These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.

Key Figures

Stock options granted: 2,647 options Option exercise price: $100.94 per share Deferred stock units granted: 813 units +1 more

4 metrics

Stock options granted 2,647 options Grant to director on May 8, 2026

Option exercise price $100.94 per share Conversion or exercise price for granted options

Deferred stock units granted 813 units Director equity award on May 8, 2026

DSU vesting date June 1, 2027 Single-installment vesting for deferred stock units

Key Terms

Deferred Stock Units, Stock Option (right to buy), Grant, award, or other acquisition, vested and became exercisable, +1 more

5 terms

Deferred Stock Units financial

"Each deferred stock unit represents a contingent right to receive one share of ESAB common stock."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Stock Option (right to buy) financial

"Stock Option (right to buy) with a conversion or exercise price of 100.9400."

Grant, award, or other acquisition financial

"Transaction code description is Grant, award, or other acquisition for both transactions."

vested and became exercisable financial

"These stock options vested and became exercisable on the grant date."

settled in ESAB common stock financial

"Once vested, the units will be settled in ESAB common stock after the director's separation from the Company."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ESAB (ESAB) director Robert S. Lutz report in this Form 4?

Robert S. Lutz reported receiving new equity awards from ESAB Corp, including stock options and deferred stock units. These are compensation-related grants, not open-market trades, and increase his potential future ownership in ESAB common stock if the awards vest and are exercised.

How many stock options did ESAB (ESAB) grant to director Robert S. Lutz?

ESAB granted Robert S. Lutz 2,647 stock options as part of his director compensation. These options carry an exercise price of $100.94 per share, vested immediately on the grant date, and are exercisable until their stated expiration date, providing long-term equity exposure.

What are the terms of the deferred stock units granted by ESAB (ESAB)?

Lutz received 813 deferred stock units from ESAB, each representing a contingent right to one ESAB common share. These units vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after his separation from the company, subject to continued service.

Are the ESAB (ESAB) Form 4 transactions open-market buys or sells?

The transactions disclosed are not open-market purchases or sales. They are grants of stock options and deferred stock units classified as “Grant, award, or other acquisition,” reflecting routine director compensation rather than discretionary trading activity in ESAB common stock.

What is the exercise price and expiration for Robert S. Lutz’s ESAB stock options?

The granted stock options have a conversion or exercise price of $100.94 per share. They vested and became exercisable on the grant date and are scheduled to expire on May 7, 2033, giving a multi-year window during which they can be exercised.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 04:47 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUTZ ROBERT S

(Last) (First) (Middle)

909 ROSE AVE, 8TH FLOOR

(Street)

NORTH BETHESDA MARYLAND 20852

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ESAB Corp [ ESAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$100.94	05/08/2026		A		2,647		05/08/2026(1)	05/07/2033	Common stock, par value $0.001	2,647	$0	2,647	D
Deferred Stock Units	(2)	05/08/2026		A		813		(3)	(3)	Common stock, par value $0.001	813	$0	813	D

Explanation of Responses:

1. These stock options vested and became exercisable on the grant date.

2. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.

3. These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.

Remarks:

	/s/ Curtis E. Jewell, Attorney-in-Fact	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)